Striatonigral Degeneration

Striatonigral degeneration is a sporadic, progressive neurodegenerative disorder resulting from a disrupted connection between the striatum and substantia nigra, affecting balance and movement. This feed follows the research intop this disease.

September 7, 2021

Pathologic characterization of canine multiple system degeneration in the Ibizan hound.

Veterinary Pathology
Samantha C St JeanBrian F Porter
August 27, 2021
Open Access

Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson's Disease.

International Journal of Molecular Sciences
Claudio GiulianoSilvia Cerri
August 26, 2021

Benefits of betanin in rotenone-induced Parkinson mice.

Metabolic Brain Disease
Wachiryah Thong-AsaSuchawalee Jutarattananon
August 24, 2021
Review

Toxic Feedback Loop Involving Iron, Reactive Oxygen Species, α-Synuclein and Neuromelanin in Parkinson's Disease and Intervention with Turmeric.

Molecular Neurobiology
Zuné Jansen van RensburgColin Kenyon
August 15, 2021

DNAJB6 suppresses alpha-synuclein induced pathology in an animal model of Parkinson's disease.

Neurobiology of Disease
Sertan ArkanChristian Hansen
August 14, 2021
Review

Dopamine in Parkinson's disease.

Clinica Chimica Acta; International Journal of Clinical Chemistry
Saad LatifMohammad Azam Ansari
August 12, 2021

Role of the nigrosome 1 absence as a biomarker in amyotrophic lateral sclerosis.

Journal of Neurology
María Isabel Moreno-GambínJuan F Vázquez-Costa
August 9, 2021
Preprint
Open Access

Kv4.3 channel downregulation mediates chronic post-lesional pacemaker acceleration in surviving dopamine substantia nigra neurons

BioRxiv : the Preprint Server for Biology
L. KovachevaJochen Roeper
August 9, 2021

Locus Coeruleus Degeneration Correlated with Levodopa Resistance in Parkinson's Disease: A Retrospective Analysis.

Journal of Parkinson's Disease
Cheng ZhouMinming Zhang
August 6, 2021
Review
Open Access

Animal Models of Autosomal Recessive Parkinsonism.

Biomedicines
Guendalina BastioliJenny Sassone
July 30, 2021
Open Access

A β-Wrapin Targeting the N-Terminus of α-Synuclein Monomers Reduces Fibril-Induced Aggregation in Neurons.

Frontiers in Neuroscience
Éva M SzegőBjörn H Falkenburger
July 29, 2021
Review
Open Access

Neuropathology of multiple system atrophy: Kurt Jellinger`s legacy.

Journal of Neural Transmission
Nicole CampeseGregor K Wenning
July 27, 2021
Case Report

An autopsy case report of neuronal intermediate filament inclusion disease presenting with predominantly upper motor neuron features.

Neuropathology : Official Journal of the Japanese Society of Neuropathology
Aya MurakamiHirofumi Kusaka

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/striatonigral-degeneration/d92398fd-51aa-4e25-93c1-3730971831d2